Sir Charles Gairdner Hospital
Perth, Western Australia, 6009, Australia
NCT Number: NCT00798993
This study aims to examine the effect of 25 hydroxyvitamin D supplementation and a structured exercise program on the exercise capacity and quality of life of haemodialysis patients with 25 hydroxyvitamin D insufficiency.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 4
Perth, Western Australia, 6009, Australia
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
30 minutes on an exercise bicycle during every dialysis
Cholecalciferol 2000U per day will be given for duration of study to all participants
Participants randomised to this arm at 3 months will continue on their usual exercise routine for the remaining 3 months
Time frame: Basesline, 3 & 6 months
Time frame: Baseline, 3 & 6 months
Time frame: Baseline, 3 & 6 months
Time frame: baselibe, 3 & 6 months
Time frame: Baseline, 3 & 6 months
Time frame: baseline, 3 & 6 months
Time frame: continuous
Time frame: baseline, 3 & 6 months
Time frame: Baseline, 3 & 6 months
Sir Charles Gairdner Hospital
Other
The Effect of 25-hydroxyvitamin D Supplementation and a Structured Exercise Program on Exercise Capacity and Quality of Life in Dialysis Patients
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05241171
Behavior, Chronic Disease
San Diego, California, United States
View Trial DetailsNCT00792454
Behavior, Cardiovascular Disease
Portland, Maine, United States
View Trial DetailsNCT02513303
Arteriovenous Fistula, Arteriovenous Malformations
Huntsville, Alabama, United States
View Trial DetailsNCT05425056
Arteriovenous Fistula, Arteriovenous Malformations
San Diego, California, United States
View Trial Details